Cystathionine-γ-lyase-IN-1

CAS No. 2165706-30-7

Cystathionine-γ-lyase-IN-1( —— )

Catalog No. M35800 CAS No. 2165706-30-7

Cystathionine-γ-lyase-IN-1 (SHIP-2a) is a selective inhibitor of cystathionine γ-lyase (CSE) enzyme (IC50= 6.3 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 32 In Stock
5MG 51 In Stock
10MG 85 In Stock
25MG 179 In Stock
50MG 281 In Stock
100MG 439 In Stock
200MG 643 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cystathionine-γ-lyase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Cystathionine-γ-lyase-IN-1 (SHIP-2a) is a selective inhibitor of cystathionine γ-lyase (CSE) enzyme (IC50= 6.3 μM).
  • Description
    Cystathionine-γ-lyase-IN-1 is a selective cystathionine γ-lyase (CSE) enzyme inhibitor with an IC50 of 6.3 μM. Cystathionine-γ-lyase-IN-1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2165706-30-7
  • Formula Weight
    184.22
  • Molecular Formula
    C7H8N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 18 mg/mL (97.71 mM)Ethanol : 9 mg/mL (48.85 mM)
  • SMILES
    O=C(NCC#C)[C@@H]1CSC(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Angela Corvino, et al. Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production. Sci Rep. 2016 Oct 6;6:34398.?
molnova catalog
related products
  • Piperidine-MO-1

    Piperidine-MO-1 is a dopamine receptor modulator.

  • CCTA-1523

    CCTA-1523 is an efflux function of ABCG2 inhibitor. CCTA-1523 selectively reverses ABCG2-mediated MDR in cancer cells.

  • Biotin-LC-LC-NHS

    Biotin-LC-LC-NHS, an SMCC cross-linking reagent, acts as a labeling agent for antibodies and small molecules (like Paclitaxel).